# FDA recall D-0120-2018

> **Amneal Pharmaceuticals of New York, LLC** · Class I · drug recall initiated 2017-08-03.

## Product

Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ 08876. Distributed by: Amneal Pharmaceuticals, Glasgow, KY 42141. NDC 65162-687-84

## Reason for recall

Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0120-2018
- **Recalling firm:** Amneal Pharmaceuticals of New York, LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-08-03
- **Report date:** 2017-12-27
- **Termination date:** 2022-09-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Brookhaven, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0120-2018

## Citation

> AI Analytics. FDA recall D-0120-2018. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-0120-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*